Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.345
+0.025 (1.89%)
Mar 16, 2026, 9:51 AM EDT - Market open
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $46.24 million as of March 16, 2026. Its market cap has decreased by -60.26% in one year.
Market Cap
46.24M
Enterprise Value
38.15M
1-Year Change
-60.26%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $46.24M, a decrease of -77.69%. That is a compound annual growth rate of -51.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 45.38M | -0.75% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 47.58M |
| Atara Biotherapeutics | 46.87M |
| Aligos Therapeutics | 46.84M |
| MiNK Therapeutics | 45.72M |
| Lisata Therapeutics | 45.43M |
| NextCure | 45.15M |
| Nutriband | 44.89M |
| Atossa Therapeutics | 43.14M |